Orthofix Medical Inc.(OFIX)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Orthofix Medical Inc. (OFIX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores OFIX at 38.2/100 on a 32-signal composite quality model, placing it at rank #2,209 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (19.7) and free cash flow (21.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 30.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Orthofix Medical Inc. reports quarterly revenue of $210.9M, net income of $-15.8M, an operating margin of -3.9%. Top institutional holders of OFIX by reported 13-F value include Engine Capital Management, Juniper Investment Company, Rubric Capital Management, based on the most recent SEC filings. OFIX trades on the Nasdaq exchange and files with the SEC under CIK 884624. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OFIX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Orthofix Medical Inc. directly from SEC EDGAR.